Selective and potent antagonists for the A2A adenosine receptors have been described recently. The most potent compds. have a triazolo-pyrimidine structure, whereas 8-styryl-xanthines usually possess lower affinity at the A2A receptor. We have examd. the quant. structure activity relationships of 34 triazolo-pyrimidines using the Comparative Mol. Field Anal. (CoMFA). The model developed accounts in a satisfactory manner for the structure-activity relationships within this series of A2A receptor antagonists (q2 = 0.840, r2 = 0.970) and, consequently, it can be used as a guide in the design of novel analogs with optimized antagonistic activity. The overall predictivity of this model was tested on the published data of a set of exter...
The interaction of 278 monocyclic and bicyclic pyrimidine derivatives with human A(2A) adenosine rec...
A review. In the last years adenosine receptors have been extensively studied, and mainly at presen...
A new series of potential adenosine receptor antagonists with a [1,2,4]-triazolo-[3,4-f]-purine stru...
Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists ...
We present a combined computational study aimed at identifying the three-dimensional structural prop...
Molecular modeling studies, including the comparative molecular field analysis (CoMFA) method, on 52...
The application of both structure- and ligandbased design approaches represents to date one of the m...
We present a combined computational study aimed at identifying the three-dimensional structural prop...
The application of both structure- and ligand-based design approaches represents to date one of the ...
Adenosine is a neuromodulator whose biological functions are accomplished through the activation of ...
The binding affinity and relative maximal efficacy of human A_3 adenosine receptor (AR) agonists wer...
Extracellular adenosine signalling is mainly conferred through adenosine receptors, including the ad...
We present a robust protocol based on iterations of free energy perturbation (FEP) calculations, ch...
Adenosine Receptor Type 2A (A2AAR) plays a role in important processes, such as anti-inflammatory on...
The integration of ligand- and structure-based strategies might sensitively increase the success of ...
The interaction of 278 monocyclic and bicyclic pyrimidine derivatives with human A(2A) adenosine rec...
A review. In the last years adenosine receptors have been extensively studied, and mainly at presen...
A new series of potential adenosine receptor antagonists with a [1,2,4]-triazolo-[3,4-f]-purine stru...
Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists ...
We present a combined computational study aimed at identifying the three-dimensional structural prop...
Molecular modeling studies, including the comparative molecular field analysis (CoMFA) method, on 52...
The application of both structure- and ligandbased design approaches represents to date one of the m...
We present a combined computational study aimed at identifying the three-dimensional structural prop...
The application of both structure- and ligand-based design approaches represents to date one of the ...
Adenosine is a neuromodulator whose biological functions are accomplished through the activation of ...
The binding affinity and relative maximal efficacy of human A_3 adenosine receptor (AR) agonists wer...
Extracellular adenosine signalling is mainly conferred through adenosine receptors, including the ad...
We present a robust protocol based on iterations of free energy perturbation (FEP) calculations, ch...
Adenosine Receptor Type 2A (A2AAR) plays a role in important processes, such as anti-inflammatory on...
The integration of ligand- and structure-based strategies might sensitively increase the success of ...
The interaction of 278 monocyclic and bicyclic pyrimidine derivatives with human A(2A) adenosine rec...
A review. In the last years adenosine receptors have been extensively studied, and mainly at presen...
A new series of potential adenosine receptor antagonists with a [1,2,4]-triazolo-[3,4-f]-purine stru...